Related Experiment Video
Updated: Jun 10, 2026
06:08
Formulating and Characterizing an Exosome-based Dopamine Carrier System
Published on: April 4, 2022
Exosomes in Parkinson's Disease: Current Perspectives and Future Challenges
1Institute of Health Science , China Medical University , Shenyang 110122 , China.
ACS Chemical Neuroscience
|January 22, 2019
Summary
Exosomes carry pathological proteins like alpha-synuclein, crucial for Parkinson's disease (PD) research. These vesicles show potential as biomarkers and drug delivery vehicles to combat PD progression.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Exosomes are lipid bilayer vesicles involved in intercellular communication.
- Extracellular alpha-synuclein, linked to exosomes, is central to Parkinson's disease pathogenesis.
- Exosomes may serve as biomarkers for Parkinson's disease due to altered contents.
Purpose of the Study:
- To review the biogenesis and pathophysiological roles of exosomes in Parkinson's disease.
- To explore the potential of exosomes as therapeutic delivery vehicles for brain targeting.
- To discuss applications of modified exosomes for halting Parkinson's disease propagation.
Main Methods:
- Literature review on exosome biogenesis and function in Parkinson's disease.
- Analysis of studies on extracellular alpha-synuclein and exosome association.
- Evaluation of exosome-based drug delivery systems for neurological disorders.
Main Results:
- Exosomes facilitate the spread of pathological alpha-synuclein in Parkinson's disease.
- Exosome content alterations offer potential for Parkinson's disease biomarker development.
- Engineered exosomes can deliver therapeutic molecules, including RNA and drugs, to the brain.
Conclusions:
- Exosomes play a significant role in Parkinson's disease progression.
- Exosomes are promising for developing novel biomarkers and targeted drug delivery systems.
- Modified exosome-based therapies could offer new strategies to halt Parkinson's disease.
Related Concept Videos
01:36Overview of Exosomes
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...